Good morning :)
$
₹
Eloxx Pharmaceuticals, Inc.

Eloxx Pharmaceuticals, Inc.

ELOX

NASDAQ
$13.182.96% (+0.38)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Biotechnology

Micro Cap

With a market cap of $51.7M the stock is ranked 5035

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

3.63
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

1.23
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$3.52
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

—
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

0%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 5 analysts reports

Buy
5 analysts
Hold
0 analyst
Sell
0 analyst

Price Upside

+198.83%

Earnings Growth

—

Rev. Growth

—

See Detailed Forecast

Company Profile

Company Profile

P/E Ratio
42.74
42.74
1Y Return
55.33%
55.33%
Buy Reco %
83.87
83.87
P/E Ratio
40.03
40.03
1Y Return
37.93%
37.93%
Buy Reco %
69.56
69.56
P/E Ratio
115.29
115.29
1Y Return
66.63%
66.63%
Buy Reco %
70.37
70.37
P/E Ratio
22.82
22.82
1Y Return
14.79%
14.79%
Buy Reco %
41.66
41.66
P/E Ratio
25.78
25.78
1Y Return
1.93%
1.93%
Buy Reco %
83.33
83.33
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Financials

Financials

Income

Balance Sheet

Cash Flow

-1.7
-1.8
-3.7
-4.5
Q1 2025
Q2 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ2 2022Q3 2022Q4 2022Q1 2023Q2 2023Q3 2023Q1 2025Q2 2025Q1 2026Q2 2026
Total Revenue------0000
Net Income-10.61-7.50-6.31-6.23-4.34-3.59-1.70-1.89-3.75-4.50
Net Profit Margin----------

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareBiotechnology
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Eloxx Pharmaceuticals, Inc. 3.631.23-
Eli Lilly and Company42.7430.781.15
Johnson & Johnson40.037.632.82

Price Comparison

Price Comparison

Compare ELOX with any stock or ETF
Compare ELOX with any stock or ETF
Comparing from
ELOX
LLY
JNJ
Loading...

Frequently asked questions

  1. Eloxx Pharmaceuticals, Inc. (ELOX) share price today is $13.18 as of October 27, 2026 at 12:12 AM IST. The stock touched a day high of $13.36 and a day low of $12.69.

  2. Eloxx Pharmaceuticals, Inc. stock trades on NASDAQ under the ticker symbol ELOX.

  3. Eloxx Pharmaceuticals, Inc.'s market capitalization is $51.66M as of October 27, 2026 at 12:12 AM IST.

  4. Eloxx Pharmaceuticals, Inc.'s price-to-earnings (P/E) ratio is 3.63 as of October 26, 2026.

  5. Eloxx Pharmaceuticals, Inc.'s price-to-book (P/B) ratio is 1.23 as of October 26, 2026.

  6. Yes, You can buy Eloxx Pharmaceuticals, Inc. shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Eloxx Pharmaceuticals, Inc. shares in three steps: 1. Search Eloxx Pharmaceuticals, Inc. on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Eloxx Pharmaceuticals, Inc. trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Eloxx Pharmaceuticals, Inc. (ELOX) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.7587 shares at the current price of $13.18.

Loading...